Masato Yoneda

medborgare i: Japan

sysselsättning: forskare

Serier

Det finns ingenting här

Skapa en ny serie

Verk

Det finns ingenting här

Skapa ett nytt verk

Artiklar 288

Datum

Titel

Författare

2022-01-01

Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2022-01-15

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Hideyuki Hyogo, Hidenori Toyoda, Michihiro Iwaki, Shinichi Aishima, Satoshi Oeda, Miwa Kawanaka, Kensuke Munekage, Sakura Yamamura, Takumi Kawaguchi, Masafumi Ono, Eiichi Tomita, Norifumi Kawada, Yoshihiro Kamada, Yoshio Sumida, Takeshi Okanoue
2022-07-15

Diagnostic accuracy of non-invasive tests for fibrotic NASH-An individual participant data meta-analysis

Atsushi Nakajima, Masato Yoneda
2022-07-15

Diagnostic accuracy of non-invasive tests for cirrhotic NASH-an individual participant data meta-analysis

Atsushi Nakajima, Masato Yoneda
2021-07-29

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2021-05-17

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Ferenc E Mozes, Michael Trauner, Jerome Boursier, Elisabetta Bugianesi, Ramy Younes, Salvatore Petta, Sanjiv Mahadeva, Philip Newsome, Vincent Wai-Sun Wong, Christian Labenz, Johannes Wiegand, Thomas Karlas, Yusuf Yılmaz, Guruprasad P. Aithal, Christophe Cassinotto, Geraldine J Ooi, Atsushi Nakajima, Andreas Geier, Michael Pavlides, Masato Yoneda
2020-02-23

Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease

Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Takaomi Kessoku, Kento Imajo, Shinichi Aishima, Satoshi Oeda, Yuichiro Eguchi, Michiaki Okada, Hiroshi Isoda, Keizo Anzai
2020-02-26

Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver

Takashi Kobayashi, Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2020-03-11

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis

Yoshio Sumida, Kento Imajo, Takumi Kawaguchi, Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Hideyuki Hyogo, Yuichi Nozaki, Miwa Kawanaka, Masafumi Ono, Yoshihiro Kamada, Takeshi Okanoue, Yuichiro Eguchi, Katsutoshi Tokushige, Masashi Yoneda, Japan Study Group Of Nafld Jsg-Nafld
2020-04-01

Current and new pharmacotherapy options for non-alcoholic steatohepatitis

Atsushi Nakajima, Masato Yoneda
2020-03-23

Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial

Atsushi Nakajima, Masato Yoneda
2020-01-20

A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma

Atsushi Nakajima, Masato Yoneda, Satoru Saito
2020-04-26

Diagnostic accuracy of FibroScan-AST score to identify nonalcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with nonalcoholic fatty liver disease: comparison between M and XL probes

Satoshi Oeda, Takashi Kobayashi, Hiroyuki Irie, Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Kento Imajo, Shinichi Aishima, Yuichiro Eguchi, Yuya Seko, Keizo Anzai, Michihisa Moriguchi, Masayoshi Kage
2020-05-26

Metabolomic-/Lipidomic-based Analysis of Plasma to Diagnose Hepatocellular Ballooning in Patients with Nonalcoholic Fatty Liver Disease: A Multicenter Study

Takashi Kobayashi, Satoshi Oeda, Megumi Hirayama, Hideyuki Hyogo, Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Satoru Saito, Kazuaki Chayama, Takashi Nakahara, Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Takeharu Yamanaka, Yusuke Saigusa, Shinichi Aishima, Yuichiro Eguchi, Masayoshi Kage, Yuichiro Amano, Shinji Ogawa, Yuko Nagaoki, Yasushi Honda
2020-06-01

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2020-06-05

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Yasushi Honda, Kento Imajo, Atsushi Nakajima, Masato Yoneda
2020-08-03

Advances in ultrasound elastography for nonalcoholic fatty liver disease

Masato Yoneda, Atsushi Nakajima, Yasushi Honda
2020-08-10

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Yoshio Sumida, Tasuku Hara, Hidenori Toyoda, Kento Imajo, Takumi Kawaguchi, Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Toshifumi Tada, Satoshi Oeda, Eiichi Tomita, Takeshi Okanoue, Yuichiro Eguchi, Yuya Seko, Masashi Yoneda, Hiroshi Ishiba, Japan Study Group Of Nafld Jsg-Nafld, Takashi Kumada
2020-08-14

Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2020-09-09

Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease

Takaomi Kessoku, Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2020-09-25

Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype

Atsushi Nakajima, Masato Yoneda, Yasushi Honda
2020-10-27

Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2020-11-07

Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs

Kento Imajo, Takashi Kobayashi, Yasushi Honda, Atsushi Nakajima, Masato Yoneda, Satoru Saito
2020-12-16

Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease

Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Satoru Saito, Hiroyuki Kirikoshi, Takaomi Kessoku, Kento Imajo, Michihiro Iwaki, Yusuke Saigusa, Shinichi Aishima, Yasushi Honda
2019-04

Nonalcoholic fatty liver disease with advanced fibrosis as a multi-systemic disease: proceed with caution

Atsushi Nakajima, Masato Yoneda
2019-02-03

HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease

Hideki Fujii, Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Kazuaki Chayama, Hideyuki Hyogo, Takashi Nakahara, Kento Imajo, Norifumi Kawada, Yoshio Sumida, Saiyu Tanaka, Yuichiro Eguchi
2019-01-06

Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda
2019-10-01

Relationship between Stool Form and Quality of Life in Patients with Chronic Constipation: An Internet Questionnaire Survey

Atsushi Nakajima, Masato Yoneda, Satoru Saito
2019-10-25

Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study

Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Kento Imajo, Shinichi Aishima, Satoshi Oeda, Yuichiro Eguchi, Yuya Seko, Keizo Anzai, Michihisa Moriguchi, Masayoshi Kage
2019-12-02

Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility

Daisuke Utsunomiya, Atsushi Nakajima, Masato Yoneda, Kensuke Kubota
2019-06-21

Infection phase is a predictor of pruritus in patients with hepatitis B virus infection

Atsushi Nakajima, Hirokazu Takahashi, Masato Yoneda, Hideyuki Hyogo, Kento Imajo, Satoshi Oeda, Miwa Kawanaka, Takumi Kawaguchi, Masafumi Ono, Yoshio Sumida, Saiyu Tanaka, Takuji Torimura, Toshiji Saibara, Yuichiro Eguchi, Hiroshi Isoda
2019-07-04

Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Atsushi Nakajima, Masato Yoneda, Satoru Saito, Yasushi Honda

Människa - wd:Q98197206

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer